AstraZeneca (AZNL)

14,079.00p
   
  • Change Today:
      2.27p
  • 52 Week High: 15,253.00
  • 52 Week Low: 9,642.00
  • Currency: UK Pounds
  • Shares Issued: 1,264.16m
  • Volume: 295,715
  • Market Cap: £177,982m

AstraZeneca Overview

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

1 Day Chart (25-03-2026)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 1.5%
Div Cover 2.1
Op Mrgn 23.4%
ROCE 58.0%
Latest F'cast
P/E 31.6
PEG 0.7
Pr/Revenue 4.5
Pr/Book 5.4
Latest F'cast
Revenue 8.6%
PBT 42.7%
EPS 45.4%
DPS 3.2%

AstraZeneca Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 37,417.00 (265.00) 8.00¢ 1,445.2 n/a -97% 287.00¢ 2.5%
31-Dec-22 44,351.00 2,501.00 212.00¢ 70.8 0.0 +2,550% 290.00¢ 1.9%
31-Dec-23 45,811.00 6,899.00 726.00¢ 19.5 0.1 +242% 290.00¢ 2.1%
31-Dec-24 54,073.00 8,691.00 454.00¢ 30.8 n/a -38% 310.00¢ 2.2%
31-Dec-25 58,739.00 12,402.00 660.00¢ 27.9 0.6 +45% 320.00¢ 1.7%

AstraZeneca Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-26 62,769.11 20,239.83 761.46p 18.2 n/a n/a 250.18p 0.0%
31-Dec-27 66,658.88 22,428.01 855.30p 16.2 1.3 +12% 261.63p 0.0%
31-Dec-28 70,666.24 24,305.88 939.65p 14.7 1.5 +10% 265.95p 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

AstraZeneca Company Announcements

Imfinzi approved in EU for early gastric cancer 16-Mar-2026 07:00 RNS
Notice of AGM 10-Mar-2026 11:00 RNS
Director/PDMR Shareholding 22-Dec-2025 11:00 RNS

AstraZeneca ShareCast News

Director/PDMR Shareholding 22-Dec-2025 ShareCast
Enhertu granted BTD for post-neoadjuvant early BC 22-Dec-2025 ShareCast
Update on LATIFY Phase III trial of ceralasertib 22-Dec-2025 ShareCast

AstraZeneca Top Newspaper Links

Fighting Frenchman shows us how as he ensures As... 30-Dec-2014 Daily Mail
Exclusive: UK firms vie for share of £170bn in A... 08-Dec-2014 The Independent
MARKET REPORT: Ariad on the up amid growing spec... 04-Dec-2014 Daily Mail

Latest AstraZeneca Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

Note 2: Forecast figures based on normalised accounts.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 14,079.00p
Change Today 2.27p
% Change 1.64 %
52 Week High 15,253.00
52 Week Low 9,642.00
Volume 295,715
Shares Issued 1,264.16m
Market Cap £177,982m

What The Brokers Say

Strong Buy 10
Buy 13
Neutral 3
Sell 0
Strong Sell 1
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 25-Mar-2026

Time Volume / Share Price
16:29 3 @ 14,079.00p
16:29 16 @ 14,080.00p
16:29 139 @ 14,078.00p
16:29 2 @ 14,078.00p
16:29 122 @ 14,078.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page